Skip to content

Hair growth trial

Evaluate hair growth effect by long-term use of study sample - Hair growth trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049996
Enrollment
20
Registered
2023-01-10
Start date
2023-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

The study sample is applied twice daily to the scalp in prescribed amounts for 18 weeks. Placebo is applied twice daily to the scalp in prescribed amounts for 18 weeks.

Sponsors

Nikoderm Research Inc.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese females aged 40 to 69 at the time of informed consent 2. Subjects who is worried about thinning hair and hair loss 3. Subjects who agree to keep the conditions such as hair conditioning and hair dyeing constant on each visiting day 4. Subjects who agree to cut hair locally approximately 1.0 cm x 1.0 cm near the crown on each visiting day 5. Subjects who have signed a consent at own discretion before the start of the study

Exclusion criteria

Exclusion criteria: 1. Subjects with pathological hair loss such as alopecia areata 2. Subjects with scalp diseases other than hair loss (eg, head eczema, seborrheic eczema, psoriasis, tinea capitis, and other scalp infections) 3. Subjects who regularly apply external application or take oral medicines, supplements, etc. that may affect the condition of the head 4. Subjects with a history of hypersensitivity (allergies) to hair growth agents, hair restorer, cosmetics (shampoo, etc.), or hypersensitivity to other medicines. 5. Subjects who have used existing hair growth agents and hair restorer within the past 2 months, regardless of whether they are pharmaceutical products or quasi-drugs. 6. Subjects who regularly use wigs during the study period, subjects who have undergone hair transplantation or hair growth, or subjects who are scheduled during the study period 7. Subjects currently using medications known to cause trichotillomania or hirsutism (eg, phenytoin for epilepsy) 8. Subjects undergoing hormone replacement therapy or taking oral contraceptives 9. Subjects who are pregnant or lactating, or who intend to become pregnant 10. Subjects who have participated in another clinical study within the past month or those who plan to participate during the study period 11. Subjects judged inappropriate for this study

Design outcomes

Primary

MeasureTime frame
Photo Trichogram (Hair number, Hair growth rate, Hair diameter, Anagen hair percentage)

Secondary

MeasureTime frame
Photography of area at top of head and investigation of adverse event

Countries

Japan

Contacts

Public ContactAyaka Taniguchi

R&D Center, Nikko Chemicals Co., Ltd. under constraction

volunteer@nikkolgroup.com080-4249-0198

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026